BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34817543)

  • 1. Assessing the Potential for Patient-led Surveillance After Treatment of Localized Melanoma (MEL-SELF): A Pilot Randomized Clinical Trial.
    Ackermann DM; Dieng M; Medcalf E; Jenkins MC; van Kemenade CH; Janda M; Turner RM; Cust AE; Morton RL; Irwig L; Guitera P; Soyer HP; Mar V; Hersch JK; Low D; Low C; Saw RPM; Scolyer RA; Drabarek D; Espinoza D; Azzi A; Lilleyman AM; Smit AK; Murchie P; Thompson JF; Bell KJL
    JAMA Dermatol; 2022 Jan; 158(1):33-42. PubMed ID: 34817543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial.
    Ackermann DM; Smit AK; Janda M; van Kemenade CH; Dieng M; Morton RL; Turner RM; Cust AE; Irwig L; Hersch JK; Guitera P; Soyer HP; Mar V; Saw RPM; Low D; Low C; Drabarek D; Espinoza D; Emery J; Murchie P; Thompson JF; Scolyer RA; Azzi A; Lilleyman A; Bell KJL
    Trials; 2021 May; 22(1):324. PubMed ID: 33947444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient Preferences for Follow-up After Recent Excision of a Localized Melanoma.
    Lim WY; Morton RL; Turner RM; Jenkins MC; Guitera P; Irwig L; Webster AC; Dieng M; Saw RPM; Low D; Low C; Bell KJL
    JAMA Dermatol; 2018 Apr; 154(4):420-427. PubMed ID: 29490373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability of a Hypothetical Reduction in Routinely Scheduled Clinic Visits Among Patients With History of a Localized Melanoma (MEL-SELF): Pilot Randomized Clinical Trial.
    Drabarek D; Ackermann D; Medcalf E; Bell KJL
    JMIR Dermatol; 2023 Jun; 6():e45865. PubMed ID: 37632976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences of Patient-Led Surveillance, Including Patient-Performed Teledermoscopy, in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study.
    Drabarek D; Habgood E; Janda M; Hersch J; Ackermann D; Low D; Low C; Morton RL; Dieng M; Cust AE; Morgan A; Smith E; Bell KLJ
    JMIR Dermatol; 2022 Jul; 5(3):e35916. PubMed ID: 37632893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Detection of New Melanomas by Patients With Melanoma and Their Partners Using a Structured Skin Self-examination Skills Training Intervention: A Randomized Clinical Trial.
    Robinson JK; Wayne JD; Martini MC; Hultgren BA; Mallett KA; Turrisi R
    JAMA Dermatol; 2016 Sep; 152(9):979-85. PubMed ID: 27367303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow up? Statistical analysis plan for the MEL-SELF randomised controlled trial.
    Medcalf E; Taylor A; Turner R; Espinoza D; Bell KJL
    Contemp Clin Trials; 2022 Jun; 117():106761. PubMed ID: 35439647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a Skin Self-monitoring Smartphone Application on Time to Physician Consultation Among Patients With Possible Melanoma: A Phase 2 Randomized Clinical Trial.
    Walter FM; Pannebakker MM; Barclay ME; Mills K; Saunders CL; Murchie P; Corrie P; Hall P; Burrows N; Emery JD
    JAMA Netw Open; 2020 Feb; 3(2):e200001. PubMed ID: 32101302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for reducing morbidity and mortality in malignant melanoma.
    Johansson M; Brodersen J; Gøtzsche PC; Jørgensen KJ
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012352. PubMed ID: 31157404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives and Experiences of Patient-Led Melanoma Surveillance Using Digital Technologies From Clinicians Involved in the MEL-SELF Pilot Randomized Controlled Trial: Qualitative Interview Study.
    Drabarek D; Habgood E; Ackermann D; Hersch J; Janda M; Morton RL; Guitera P; Soyer HP; Collgros H; Cust AE; Saw RP; Emery J; Mar V; Dieng M; Azzi A; Lilleyman A; Bell KJ
    JMIR Dermatol; 2022 Dec; 5(4):e40623. PubMed ID: 37632906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin Surveillance.
    Guitera P; Menzies SW; Coates E; Azzi A; Fernandez-Penas P; Lilleyman A; Badcock C; Schmid H; Watts CG; Collgros H; Liu R; van Kemenade C; Mann GJ; Cust AE
    JAMA Dermatol; 2021 May; 157(5):521-530. PubMed ID: 33729464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Quality of Relationship Between Patient With Melanoma and Partner on Partner-Assisted Skin Examination Education: A Randomized Clinical Trial.
    Hultgren BA; Turrisi R; Mallett KA; Ackerman S; Robinson JK
    JAMA Dermatol; 2016 Feb; 152(2):184-90. PubMed ID: 26422745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving integrated self-directed Cancer aftercare (ASICA) for melanoma: how a digital intervention to support total skin self-examination was used by people treated for cutaneous melanoma.
    Reilly F; Contstable L; Brant W; Rahman K; Durrani A; Burrows N; Proby C; Allan J; Johnston M; Johnston D; Walter F; Murchie P
    BMC Cancer; 2021 Nov; 21(1):1217. PubMed ID: 34774015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total skin self-examination at home for people treated for cutaneous melanoma: development and pilot of a digital intervention.
    Murchie P; Allan JL; Brant W; Dennis M; Hall S; Masthoff J; Walter FM; Johnston M
    BMJ Open; 2015 Aug; 5(8):e007993. PubMed ID: 26251412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot trial of mobile, patient-performed teledermoscopy.
    Manahan MN; Soyer HP; Loescher LJ; Horsham C; Vagenas D; Whiteman DC; Olsen CM; Janda M
    Br J Dermatol; 2015 Apr; 172(4):1072-80. PubMed ID: 25418126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical skin examination outcomes after a video-based behavioral intervention: analysis from a randomized clinical trial.
    Janda M; Youl P; Neale R; Aitken J; Whiteman D; Gordon L; Baade P
    JAMA Dermatol; 2014 Apr; 150(4):372-9. PubMed ID: 24553807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin self-examination education for early detection of melanoma: a randomized controlled trial of Internet, workbook, and in-person interventions.
    Robinson JK; Gaber R; Hultgren B; Eilers S; Blatt H; Stapleton J; Mallett K; Turrisi R; Duffecy J; Begale M; Martini M; Bilimoria K; Wayne J
    J Med Internet Res; 2014 Jan; 16(1):e7. PubMed ID: 24418949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Skin Examination Behaviors and Thinner Nodular vs Superficial Spreading Melanoma at Diagnosis.
    Dessinioti C; Geller AC; Stergiopoulou A; Swetter SM; Baltas E; Mayer JE; Johnson TM; Talaganis J; Trakatelli M; Tsoutsos D; Tsourouflis G; Stratigos AJ
    JAMA Dermatol; 2018 May; 154(5):544-553. PubMed ID: 29710122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin self-examination in patients at high risk for melanoma: a pilot study.
    Phelan DL; Oliveria SA; Christos PJ; Dusza SW; Halpern AC
    Oncol Nurs Forum; 2003; 30(6):1029-36. PubMed ID: 14603360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.